New Cerba Research and Biokortex Partnership
Cerba Research has announced a new partnership with Biokortex to leverage patient biological and medical data to support drug developers and CROs with patient identification and recruitment activity.
The benefits of this new partnership include patients’ biological and medical data from over 25 million patients per year from over 1,000 sites located in Europe, Africa, and North America, a platform for screening and companion diagnostic testing across Europe and Africa, and more.
Click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
How the NIMBLE Study Supported Adherence With Quarterly Dosing of CemdisiranSeptember 18th 2025
Everything to Know About FDA’s Push Towards Radical Transparency in 2025September 17th 2025
IQVIA and Veeva Join Forces to Improve Efficiency and Patient OutcomesSeptember 17th 2025
Managing Background Therapies in the NIMBLE Phase III TrialSeptember 17th 2025
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
